As a Postdoctoral Scholar in the Urology department at UCSF, my research has been dedicated to understanding and addressing drug resistance mechanisms in breast cancer and other aggressive tumors. Currently, my research focuses on uncovering novel molecular mechanisms that underlie the emergence of drug-tolerant persister cells, with a specific emphasis on enhancing the efficacy of treatments for ER-positive breast cancer patients. During my research journey, I have co-authored research publications that delve into the intricate interactions between oncoproteins and transcription factors. Additionally, my work has explored the role of targeted therapies and therapeutic antibodies in the context of cancer treatment. Through my work, I have been able to identify potential therapeutic targets and develop strategies aimed at overcoming resistance to existing therapies.